Epigenetics in carcinogenesis and cancer prevention

Annals of the New York Academy of Sciences

Volumn 983, Issue , 2003, Pages 213-219

  Jones, Peter A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

5 Methylcytosine; Carcinogenesis; CpG island; Epigenetics

Indexed keywords

ANIMAL CELL; CANCER PREVENTION; CARCINOGENESIS; CELL DIVISION; CONFERENCE PAPER; CPG ISLAND; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SILENCING; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GROWTH INHIBITION; MAMMAL CELL; METHYLATION; NONHUMAN;

ANIMALIA; MAMMALIA;

EID: 0037356316     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb05976.x     Document Type: Conference Paper

References (40)

1. BRANDEIS, M., M. ARIEL & H. CEDAR. 1993. Dynamics of DNA methylation during development. Bioessays 15: 709-713.
2. MONK, M. 1990. Changes in DNA methylation during mouse embryonic development in relation to X-chromosome activity and imprinting. Philos. Trans. R. Soc. Lond. B Biol. Sci. 326: 299-312.
3. DROUIN, R. & J.P. THERRIEN. 1997. UVB-induced cyclobutane pyrimidine dimer frequency correlates with skin cancer mutational hotspots in p53. Photochem. Photobiol. 66: 719-726.
4. AINSCOUGH, J.F. et al. 1997. Imprinting of Igf2 and H19 from a 130 kb YAC transgene. Development 124: 3621-3632.
5. BIRGER, Y. et al. 1999. The imprinting box of the mouse Igf2r gene. Nature 397: 84-88.
6. BESTOR, T.H. 2000. The DNA methyltransferases of mammals. Hum. Mol. Genet. 9: 2395-2402.
7. MAGEWU, A.N. & P.A. JONES. 1994. Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer. Mol. Cell. Biol. 14: 4225-4232.
8. BIRD, A.P. et al. 1987. Non-methylated CpG-rich islands at the human alpha-globin locus: implications for evolution of the alpha-globin pseudogene. EMBO J. 6: 999-1004.
9. BIRD, A.P. 1986. CpG-rich islands and the function of DNA methylation. Nature 321: 209-213.
10. UMAR, A. & T.A. KUNKEL. 1996. DNA-replication fidelity, mismatch repair and genome instability in cancer cells. Eur. J. Biochem. 238: 297-307.
11. UMAR, A. et al. 1997. Correction of hypermutability, N-methyl-N′-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Res. 57: 3949-3955.
12. GLAAB, W.E. & K.R. TINDALL. 1997. Mutation rate at the hprt locus in human cancer cell lines with specific mismatch repair-gene defects. Carcinogenesis 18: 1-8.
13. HERMAN, J.G. et al. 1998. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. USA 95: 6870-6875.
14. OKANO, M. et al. 1999. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99: 247-257.
15. OKANO, M., S. XIE & E. LI. 1998. Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells. Nucleic Acids Res. 26: 2536-2540.
16. BESTOR, T. et al. 1988. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J. Mol. Biol. 203: 971-983.
17. ROBERTSON, K.D. et al. 2000. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat. Genet. 25: 338-342.
18. ROUNTREE, M.R. et al. 2001. DNA methylation, chromatin inheritance, and cancer. Oncogene 20: 3156-3165.
19. ARAUJO, F.D., et al. 1999. Identification of initiation sites for DNA replication in the human dnmt1 (DNA-methyltransferase) locus. J. Biol. Chem. 274: 9335-9341.
20. REIK, W., W. DEAN & J. WALTER. 2001. Epigenetic reprogramming in mammalian development. Science 293: 1089-1093.
21. TAKAI, D. et al. 2001. Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer. Hum. Mol. Genet. 10: 2619-2626.
22. KNUDSON, A.G., JR. & A.T. MEADOWS. 1976. Developmental genetics of neuroblastoma. J. Natl. Cancer Inst. 57: 675-682.
23. NGUYEN, T.T. et al. 2000. Quantitative measure of c-ab1 and p15 methylation in chronic myelogenous leukemia: biological implications. Blood 95: 2990-2992.
24. CHIM, C.S. et al. 2001. Methylation of p15 and p16 genes in acute promyelocytic leukemia: potential diagnostic and prognostic significance. J. Clin. Oncol. 19: 2033-2040.
25. CHIM, C.S. et al. 2001. Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significance. Cancer 91: 2222-2229.
26. NGUYEN, C. et al. 2001. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells. J. Natl. Cancer Inst. 93: 1465-1472.
27. BATOVA, A. et al. 1997. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. Cancer Res. 57: 832-836.
28. UCHIDA, T. et al. 1998. High-risk myelodysplastic syndromes and hypermethylation of the p15Ink4B gene. Leuk. Lymphoma 32: 9-18.
29. QUESNEL, B. & P. FENAUX. 1999. P15INK4b gene methylation and myelodysplastic syndromes. Leuk. Lymphoma 35: 437-443.
30. GONZALEZ-ZULUETA, M. et al. 1995. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 55: 4531-4535.
31. MYOHANEN, S.K., S.B. BAYLIN & J.G. HERMAN. 1998. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res. 58: 591-593.
32. BURRI, N. et al. 2001. Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer. Lab. Invest. 81: 217-229.
33. BENDER, C.M., M.M. PAO & P.A. JONES. 1998. Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res. 58: 95-101.
34. BENDER, C.M. et al. 1999. Roles of cell division and gene transcription in the methylation of CpG islands. Mol. Cell. Biol. 19: 6690-6698.
35. GREGORY, P. & N. WANG. 1986. Alterations in the X chromosome replication pattern induced by 5-azacytidine in a human tumor line. Cancer Genet. Cytogenet. 20: 263-267.
36. LIANG, G. et al. 2002. Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol. Cell. Biol. 22: 480-491.
37. GREENBLATT, M.S. et al. 1994. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54: 4855-4878.
38. RIDEOUT, W.M., 3rd et al. 1991. 5-Methylcytosine as an endogenous mutagen in the p53 tumor suppressor gene. Princess Takamatsu Symp. 22: 207-219.
39. PFEIFER, G.P., D. GRUNBERGER & D. DRAHOVSKY. 1984. Impaired enzymatic methylation of BPDE-modified DNA. Carcinogenesis 5: 931-935.
40. PFEIFER, G.P. 2000. p53 mutational spectra and the role of methylated CpG sequences. Mutat. Res. 450: 155-166.